This new cryo-EM structure represents a remarkable advance in our understanding of how human PINK1 is stabilized” said ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next ...

Shenzhen Zhongge Biotechnology Co. Ltd. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to an interleukin-1 ...

Katalytic Therapeutics Inc. has divulged proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase binding moiety covalently linked to a phosphodiesterase PDE4-targeting ...

TRIMTECH Therapeutics’s incredible $31million seed funding haul will be deployed to develop treatments for severe ...

The applied physicist explains how the structure of 52,000-year-old genes hint at the biology of an extinct animal ...

After the presentations at the 2025 #21ToWatch ceremony at Botanic House there was a chance to meet the winners and - yes! - ...

Bacteria navigate tradeoffs between phage resistance and interbacterial competition. This study reveals that while LPS ...

This paper presents the important finding that BNIP3/NIX, a mitophagy receptor, and its binding to ATG18 are required for mitophagy during muscle cell reorganization in Drosophila. Although the ...

After hours: March 12 at 4:29:45 PM EDT Loading Chart for KPTI ...